Document is current

Any future updates will be listed below

Evaluation of treatment response and resistance in metastatic renal cell cancer (mRCC) using integrated 18F–Fluorodeoxyglucose (18F–FDG) positron emission tomography/magnetic resonance imaging (PET/MRI); The REMAP study

Crossref DOI link: https://doi.org/10.1186/s12885-017-3371-9

Published Online: 2017-06-02

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark